|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 泪道探通对三个年龄组的先天性鼻泪管阻塞患者的疗效(英文)显示文摘目的:比较泪道探通治疗对三个年龄组的先天性鼻泪管阻塞患者的成功率。方法:共180例先天性鼻泪管阻塞患者根据年龄分为3组, Ⅰ组(4 ~6mo), Ⅱ组(7 ~12mo)和Ⅲ组(13 ~24mo),均行泪道探通治疗。症状体征均消失为治疗成功的标准。用卡方检验分析结果。结果:Ⅰ组治疗成功率为100.0%, Ⅱ组治疗成功率为88.5%,Ⅲ组治疗成功率为82.3%,总的治愈率为90.7%。结论:泪道探通治疗的有效性随着年龄的增加降低。在6mo时行泪道探通治疗的孩子成功率最高,能完全消除症状。 | Siddiqa Gul Syed Asher Dabir Shafi Muhammad Jatoi Ashok Kumar Narsani Mahatab Alam | 2008 | 国际眼科杂志2008,8,5: | 8 |
| 2 | 细菌性角膜溃疡的医院流行病学,诱因和微生物诊断(英文)显示文摘目的:确定细菌性角膜溃疡的发病诱因,临床和微生物特性。方法:本研究涉及300例(300眼)临床上疑似微生物感染的角膜溃疡患者。通过病史回顾和裂隙灯检查获得病例资料。采用标准技术完成角膜刮片检查。取部分刮片样本加入100g/L的氢氧化钾液后,以及采用革兰氏和吉姆萨染色,再直接在显微镜下观察是否存在真菌、细菌和棘阿米巴。另一部分刮片样本直接接种在血琼脂、麦康基琼脂、巧克力琼脂和萨布罗琼脂表面。通过角膜刮片检查,细菌性角膜溃疡被确诊为化脓性角膜溃疡浸润和表层上皮细胞缺失伴细菌感染。对患者应用抗菌治疗。结果:在随访期间,因丢失而被排除的有60个病例。在剩下的240人中,被确诊为细菌性角膜溃疡的156人(65%),大多数为男性(102眼),年龄分布14~74岁。角膜溃疡位于角膜中央的96人(61.5%),位于外周的60人(38.5%)。溃疡深度<1/3角膜厚度的82人(52.6%)。前房炎症为:Tyndall现象和浮游细胞1+~2+64人。角膜涂片中分离出细菌的有125人(80%),其中69%为革兰氏阳性,39%为革兰氏阴性。革兰氏阴性菌感染患者伴有重症前房炎症(P=0.003)并且深度>2/3角膜厚度(P=0.001)。分离得到的最常见致病微生物为金黄色葡萄球菌。治疗后40%的患者视力恢复到入院时的水平甚至更好,其余60%的患者预后差。结论:细菌性角膜溃疡是一种严重的眼部感染性疾病,对眼部存在视力威胁,在治疗上仍具挑战性。快速分离细菌和眼部抗生素的应用是治疗此类疾病的关键。 | Ashok Kumar Narsani Shafi Muhammad Jatoi Mahesh Kumar Lohana Syed Asher Dabir Siddiqa Gul Mahtab Alam Khanzada | 2009 | 国际眼科杂志2009,9,3: | 6 |
| 3 | 巴基斯坦海德拉巴124例眼球穿通伤的临床分析(英文)显示文摘目的:分析眼球穿通伤的常见病因,确定这些病例的最终视力。方法:总共124例(124眼)年龄为6 ~60岁的眼球穿通伤患者就诊于Liaquat大学眼科,分析眼球穿通伤的常见病因及最终视力。结果:本研究包括124例眼球穿通伤患者,平均年龄35(6 ~60)岁,男性为主,占86.3%,大多数患者小于20岁(71%)。眼球穿通伤最常见于职工,占76%。51%的患者最佳矫正视力位于光感至0.1之间。我们可靠记录了124例患者的最初视力和最终视力,结果发现不良的最终视力和差的最初视力之间关系密切。结论:眼球穿通伤是一种常见事故,尤其发生在青年男性中,常导致患者眼视力下降。缺乏保护措施的工作环境和儿童玩耍危险物品是常致严重的眼外伤的原因。 | Ashok Kumar Narsani Syed Asher Dabir Siddiqa Gul Shafi Muhammad Jatoi Mahtab Alam Khanzada Mahesh Kumar | 2008 | 国际眼科杂志2008,8,11: | 2 |
| 4 | Study of the adjuvantici-ty of lysine lipopeptides;carbamate analogs elicit strong Th1and Th2response to ovalbumin in mice显示文摘 | Ismail Tabasum Shafi Syed Gupta Amit | 2011 | International Immunopharmacology2011,11,11: | 1 |
| 5 | The eight-item Morisky Medication Adherence Scale MMAS: Translation and validation of the Malaysian version显示文摘 | Harith Kh. Al-Qazaz Mohamed A. Hassali Asrul A. Shafie Syed A. Sulaiman Shameni Sundram Donald E. Morisky | 2010 | Diabetes Research and Clinical Practice2010,,2: | 1 |
| 6 | A cross-sectional validation study of EQ-5D among the Malaysian adult population 显示文摘 | Shafie AA Hassali MA Liau SY | 2011 | Qual Life Res2011,20,4: | 1 |
| 7 | PUK5 clinical and economic impacts of clinical pharmacy education on infection management among patents with chronic kidney disease in a hospital (Indonesia)显示文摘 | Nasution A Syed Sulaiman SA Shafie AA | 2012 | Value in Health2012,15,7: | 1 |
| 8 | 巴基斯坦南部84例真菌性角膜炎的研究(英文)显示文摘目的:确定真菌性角膜炎的易感因素、致病真菌,以及提高相应的实验室诊断能力。方法:240例240眼临床疑似微生物感染的角膜溃疡患者进入本研究。通过病史回溯及裂隙灯检查获得病例资料。采用标准技术完成角膜刮片检查。取部分刮片样本加入10%的氢氧化钾液后,以及采用革兰氏和吉姆萨染色,在直接在显微镜下观察是否存在真菌、细菌和棘阿米巴。另一部分刮片样本直接接种在血琼脂、麦康基琼脂、巧克力琼脂和萨布罗琼脂表面。结果:在纳入本研究的240例伴有脓性分泌物的角膜溃疡患者中,84例(35%)被确认为真菌感染。其中48例(57.1%)为男性,其余36例(42.9%)为女性。年龄分布从22-80岁。其中60例(71.4%)为农村患者,其余24例(28.6%)为城市居民。18例(21.4%)曾有植物外伤史。病变高发于10月至11月间。在84例确诊为真菌性角膜炎的患眼,致病原因为单纯真菌者74眼(80.10%),其余10眼(11.90%)为真菌合并细菌感染。分离得到的最常见致病微生物为白色念珠菌,在66眼(78.6%)中被发现。结论:在巴基斯坦南部,感染性角膜溃疡中,最常见的是真菌性角膜炎,而白色念珠菌是最常见的致病原。采用加入10%的氢氧化钾液后直接显微镜下观察是此类感染原简单、迅速、价廉及可信的诊断方法。 | Ashok Kumar Narsani Siddiqa Gul Syed Asher Dabir Shafi Muhammad Jatoi Mahtab Alam Khanzada Mahesh Kumar | 2008 | 国际眼科杂志2008,8,9: | 1 |
| 9 | AcrySof和PMMA人工晶状体植入致后发性白内障发生率的比较显示文摘目的:评价植入聚甲基丙烯酸甲酯(PMMA)人工晶状体和软性人工晶状体(AcroSof)致后发性白内障的严重程度。方法:总共100人(110眼)进行了人工晶状体植入术,随机分为两组植入不同类型的晶状体。组Ⅰ:AcrySof(SA60AT)人工晶状体,组Ⅱ:PMMA(LXIOBD)人工晶状体。分别在术后3,6,12和18mo,通过测定最佳矫正视力和数码照片拍摄评价后囊膜浑浊的密度。结果:术后3mo,PMMA组后囊膜浑浊的密度明显增加(3.6%),而Acrylic组并未发现增加。术后18mo,显著后囊膜浑浊两组的发生率相比较,Acrylic组(14.5%)较PMMA组(34.5%)低。由于PMMA人工晶状体比AcrySof人工晶状体所致后囊膜浑浊的范围广,故其导致更严重的视力降低。结论:与PMMA人工晶状体相比较,植入AcrySof人工晶状体在一定程度上有助于降低后发性白内障的发生率。 | Mahtab Alam Khanzada Siddiqa Gul Syed Asher Dabir Shafi Muhammad Jatoi Ashok Kumar Narsan | 2008 | 国际眼科杂志2008,8,12: | 0 |
| 10 | Efficiency and safety of sofosbuvir in Bangladeshi children with chronic hepatitis C virus显示文摘Background and aims:Currently,treatment with oral direct-acting antivirals is recommended for all hepatitis C virus(HCV)-infected pediatric patients.The aim of this study was to evaluate the efficacy and safety of sofosbuvir and ribavirin combination ther apy for children and adolescents in Bangladesh who are living with chronic HCV in fection.Methods:An experimental study was performed from January 2021 to December 2022.HCV polymerase chain reaction(PCR)-positive thalassemic children,who were 6–18 years of age,were enrolled by consecutive non-probability sampling.Clinical features were recorded,and investigations were performed.All patients were initially treated with sofosbuvir(200 mg for 6-to 11-year-olds and 400 mg for 12-to 18-year-olds)and ribavirin(10–15 mg/kg/day)and were assessed clinically on a four-weekly basis,along with liver-function testing.The total duration of therapy was 24 weeks.HCV PCR was done at the end of treatment and 12 weeks after the completion of treatment to see the sustained virological response.Results:There were 26 cases in total,with a mean age of 9.26?2.82 years;14 were males(53.8%),and 12 females(46.2%).Twenty-five(96.15%)patients achieved a sustained virological response,and the end-of-treatment PCR was negative.One patient(3.85%)was a nonresponder even after 24 weeks of treatment.The medication was well received,with only four patients(15.3%)reporting headaches that were reported untreated.Conclusion:The combination of sofosbuvir and ribavirin is effective in treating chronic HCV infection and is not accompanied by any major negative side effects. | Salahuddin Mahmud Jahida Gulshan MdBelayet Hossain Madhabi Baidya Rafia Rashid Farhana Tasneem Ahmed Rashidul Hasan Tanzila Farhana Mohammed Reaz Mobarak MdJahangir Alam Syed Shafi Ahmed | 2023 | iLIVER2023,2,3: | 0 |